Table 2.
Mean and Standard Deviation of baseline HRQoL scale scores of the whole patient population and by patient characteristics at baseline (N = 16,210).
| HRQoL Scale | Overall |
Age Group |
Sex |
WHO Performance Statusa |
Metastasis Status |
||||
|---|---|---|---|---|---|---|---|---|---|
| All | ≤ 60 | >60 | Male | Female | Active | Restricted | Metastatic | Non-metastatic | |
| All observations | 16,210 | 9130 | 7080 | 6647 | 9563 | 7211 | 7558 | 5709 | 8837 |
| Physical functioning | 80 (21) | 83 (20) | 76 (22) | 79 (22) | 80 (21) | 88 (16)b | 70 (23) | 75 (22) | 84 (19) |
| Role functioning | 71 (32) | 72 (31) | 70 (32) | 71 (32) | 72 (31) | 81 (26)b | 59 (33) | 67 (32) | 76 (30) |
| Emotional functioning | 73 (22) | 71 (22) | 75 (22) | 76 (22) | 70 (23) | 76 (21) | 70 (23) | 73 (22) | 73 (22) |
| Cognitive functioning | 84 (21) | 84 (20) | 83 (21) | 85 (20) | 83 (21) | 87 (18) | 80 (22) | 85 (20) | 85 (20) |
| Social functioning | 76 (28) | 76 (28) | 76 (28) | 76 (27) | 75 (28) | 82 (24)b | 66 (30) | 72 (29) | 79 (26) |
| Global health status/QoL | 65 (23) | 67 (23) | 62 (23) | 63 (23) | 66 (23) | 73 (20)b | 55 (23) | 60 (23) | 69 (22) |
| Fatigue | 33 (26) | 32 (26) | 35 (26) | 33 (26) | 33 (26) | 24 (22)b | 44 (26) | 38 (26)b | 28 (25) |
| Nausea/vomiting | 15 (20) | 14 (19) | 17 (20) | 14 (19) | 16 (20) | 9 (15)b | 23 (22) | 19 (20) | 11 (18) |
| Pain | 26 (28) | 26 (28) | 25 (28) | 26 (29) | 25 (28) | 18 (23)b | 35 (31) | 31 (29)b | 20 (25) |
| Dyspnoea | 18 (26) | 16 (25) | 21 (27) | 21 (27) | 16 (25) | 11 (21)b | 26 (29) | 25 (28)b | 13 (23) |
| Insomnia | 30 (31) | 31 (31) | 27 (30) | 27 (30) | 32 (31) | 26 (29) | 34 (32) | 31 (31) | 28 (30) |
| Appetite loss | 20 (29) | 18 (28) | 22 (31) | 20 (29) | 20 (29) | 12 (23)b | 29 (33) | 26 (31)b | 15 (26) |
| Constipation | 15 (26) | 14 (25) | 18 (28) | 15 (26) | 16 (27) | 11 (22)b | 21 (30) | 19 (28) | 12 (24) |
| Diarrhoea | 8 (18) | 8 (18) | 8 (19) | 8 (18) | 8 (19) | 7 (17) | 9 (20) | 9 (19) | 7 (17) |
| Financial problems | 17 (28) | 21 (31)b | 11 (23) | 18 (29) | 16 (28) | 15 (26) | 21 (30) | 19 (29) | 15 (27) |
a
Active WHO Performance Status (PS = 0); Restricted WHO Performance Status (PS = 1 to 4).
b
Differences that are clinically meaningful based on a 10-pt. threshold.